HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaki Kaibori Selected Research

FR136706

3/2008Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaki Kaibori Research Topics

Disease

55Hepatocellular Carcinoma (Hepatoma)
10/2022 - 03/2003
38Neoplasms (Cancer)
09/2022 - 07/2002
11Fibrosis (Cirrhosis)
03/2016 - 07/2002
10Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 07/2002
10Inflammation (Inflammations)
06/2022 - 07/2007
10Neoplasm Metastasis (Metastasis)
03/2022 - 12/2009
10Liver Diseases (Liver Disease)
10/2021 - 07/2002
10Wounds and Injuries (Trauma)
09/2021 - 02/2008
6Infections
08/2021 - 01/2005
6Liver Failure
11/2011 - 09/2006
5Cholangiocarcinoma
02/2022 - 11/2012
5Ischemia
10/2021 - 08/2006
5Acute Liver Failure (Fulminant Hepatic Failure)
10/2019 - 02/2008
4Carcinoma (Carcinomatosis)
09/2022 - 10/2010
4Reperfusion Injury
10/2021 - 02/2008
3Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 11/2018
3Pain (Aches)
01/2022 - 07/2015
3Sepsis (Septicemia)
01/2022 - 07/2011
3Stomach Neoplasms (Stomach Cancer)
01/2019 - 10/2014
3Chronic Hepatitis (Chronic Active Hepatitis)
01/2016 - 11/2008
3Hypertension (High Blood Pressure)
07/2015 - 11/2010
2Fatigue
06/2022 - 07/2015
2Diarrhea
06/2022 - 07/2015
2Insulin Resistance
05/2022 - 08/2013
2Lymphatic Metastasis
03/2022 - 04/2017
2Hypoxia (Hypoxemia)
01/2022 - 04/2004
2Diabetes Mellitus
09/2021 - 07/2015
2Necrosis
01/2020 - 01/2019
2Obesity
01/2019 - 05/2005
2Postoperative Pain
07/2015 - 06/2012
2Ulcerative Colitis
09/2014 - 01/2010
2Thrombosis (Thrombus)
11/2012 - 11/2010
2Colonic Neoplasms (Colon Cancer)
11/2012 - 09/2005
2Endotoxemia
01/2005 - 11/2004
1Hemorrhage
08/2022

Drug/Important Bio-Agent (IBA)

9Sorafenib (BAY 43-9006)FDA Link
01/2022 - 11/2010
8Messenger RNA (mRNA)IBA
01/2022 - 08/2006
8CytokinesIBA
10/2019 - 07/2002
7Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021 - 03/2003
7Proteins (Proteins, Gene)FDA Link
04/2015 - 08/2006
6Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 07/2002
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2022 - 07/2004
5AlbuminsIBA
04/2022 - 11/2008
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2010
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2020 - 08/2006
4Biomarkers (Surrogate Marker)IBA
02/2022 - 09/2014
4Serum AlbuminIBA
01/2021 - 02/2013
4AcidsIBA
06/2020 - 06/2014
4acarboxyprothrombin (PIVKA)IBA
01/2016 - 07/2004
4Vitamin KFDA Link
10/2010 - 04/2007
3Bevacizumab (Avastin)FDA Link
10/2022 - 06/2022
3atezolizumabIBA
10/2022 - 06/2022
31-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2022 - 01/2017
3lenvatinibIBA
06/2022 - 12/2021
3Pharmaceutical PreparationsIBA
01/2022 - 09/2014
3NF-kappa B (NF-kB)IBA
10/2019 - 02/2008
3EdaravoneIBA
12/2008 - 01/2005
2RNA (Ribonucleic Acid)IBA
09/2022 - 01/2022
2Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 01/2014
2BilirubinIBA
04/2022 - 11/2010
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
11/2021 - 05/2021
2Active Hexose Correlated CompoundIBA
11/2019 - 08/2014
2ChemokinesIBA
10/2019 - 03/2008
2Antineoplastic Agents (Antineoplastics)IBA
09/2019 - 01/2017
2Therapeutic UsesIBA
09/2019 - 01/2010
2Interleukin-6 (Interleukin 6)IBA
01/2019 - 09/2005
2InterleukinsIBA
01/2019 - 08/2006
2OligonucleotidesIBA
01/2018 - 04/2013
2FluvastatinFDA Link
09/2014 - 07/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2013 - 02/2008
2AntibodiesIBA
06/2012 - 05/2003
2Secretory Proteinase Inhibitory ProteinsIBA
06/2011 - 03/2008
2Free Radical ScavengersIBA
12/2008 - 01/2005
2GalactosamineIBA
06/2008 - 03/2008
2Interleukin-1beta (Interleukin 1 beta)IBA
07/2007 - 07/2002
2MucinsIBA
01/2007 - 09/2005
2Scavenger Receptors (Scavenger Receptor)IBA
01/2007 - 09/2005
2pro-hepatocyte growth factorIBA
01/2006 - 07/2002
2salicylhydroxamic acid (SHAM)IBA
07/2002 - 07/2002
1C-Reactive ProteinIBA
10/2022
1Photosensitizing Agents (Photosensitizers)IBA
09/2022

Therapy/Procedure

39Hepatectomy
01/2022 - 07/2002
16Therapeutics
09/2022 - 07/2002
12Drug Therapy (Chemotherapy)
06/2022 - 11/2010
5Blood Transfusion (Blood Transfusions)
01/2018 - 04/2007
5Liver Transplantation
06/2014 - 05/2005
4Segmental Mastectomy (Lumpectomy)
07/2022 - 11/2012
4Neoadjuvant Therapy
01/2022 - 12/2009
4Kampo Medicine (Kampo)
01/2020 - 01/2012
4Gastrectomy
01/2019 - 10/2014
3Aftercare (After-Treatment)
06/2022 - 01/2016
3Sutures (Suture)
01/2022 - 08/2016
3Adjuvant Chemotherapy
01/2022 - 07/2007
3Photochemotherapy (Photodynamic Therapy)
01/2021 - 01/2017
3Length of Stay
01/2015 - 01/2014
2Exercise Therapy (Therapy, Exercise)
05/2022 - 08/2013
2Transplantation
11/2019 - 11/2006
2Radiofrequency Ablation
01/2016 - 07/2015
2Contraindications
12/2009 - 11/2008
1Immunotherapy
10/2022